REYON Pharmaceutical Co., Ltd. (KRX:102460)
11,440
+20 (0.18%)
At close: Jun 18, 2025, 3:30 PM KST
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
Pharmaceuticals | 151.07B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Pharmaceuticals Growth | -1.93% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2016 - 2018 |
---|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2016 - 2018 |
South Korea | 149.52B |
Log In |
Log In |
Log In |
Log In | Upgrade
|
South Korea Growth | -1.42% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan | 831.00M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Japan Growth | -53.46% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vietnam | 446.77M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Vietnam Growth | 38.17% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Peru | 89.26M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Peru Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Indonesia | 63.02M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Indonesia Growth | -68.02% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Mongolia | 60.96M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Mongolia Growth | 92.36% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Thailand | 32.70M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong | 17.14M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Hong Kong Growth | -2.63% |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Malaysia | 12.40M |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Georgia | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|
Other Growth | - |
Log In |
Log In |
Log In |
Log In | Upgrade
|